, total investment, and a robust export growth. As of May 31, 2018, the Company’s total cards reached 8.24 million cards (including 2.52 million credit cards and 5.72 million member cards), net increasing
Discussion and Analysis of the Company’s Performance for the Nine Months Ended 30 September 2018 Total Revenue For the nine-month period ended 30 September 2018, the Company and its subsidiaries earned a total
17.01 319.86 Total revenues from medical services 144.88 121.38 23.50 19.36 400.68 340.79 59.89 17.57 Cost of services (127.16) (112.06) (15.09) 13.47 (362.39) (319.63) (42.76) 13.38 Revenues from dental
follows: Management Discussion and Analysis For the three months ended March 31, 2020 Summary of Performance Sales Revenue For the three months ended 31 March 2019 and 2020, the Company recorded total sales
by a company having all of the following characteristics: 1. investing in the assets under (a) (b) (c) or (d) collectively not less than seventy five percent of the company’s total asset value or
by a company having all of the following characteristics: 1. investing in the assets under (a) (b) (c) or (d) collectively not less than seventy five percent of the company’s total asset value or
shares issued by a company having all of the following characteristics: 1. investing in the assets under (a) (b) (c) or (d) collectively not less than seventy five percent of the company’s total asset
Segment 826.66 4.88 708.44 4.25 730.47 4.33 Total Sales 16,928.47 100.00 16,647.02 100.00 16,863.74 100.00 Revenue from Sales The consolidated revenue from sales for 2019 were THB 16,863.74 million
6.85 932.66 5.77 1,013.27 5.83 Inventories 3,173.50 21.19 3,653.33 22.61 3,608.19 20.78 Other Current Assets 16.27 0.11 18.15 0.11 14.10 0.08 Total Current Assets 4,808.89 32.11 4,915.01 30.41 5,371.82
ordinary shares of NU of 30,599,999 shares, equivalent to 90 percent of the total NU shares to Chirasak Chiyachantana Ph.D. Asso.Prof. at an approximate price of Baht 8.3824 per share, amounting the total of